What it offers
This initiative provides investigators with salary and project support over a 12-month period to fully develop a detailed trial protocol and grant proposal for submission to major funding agencies. Funded projects focus on testing the efficacy of diagnostic or therapeutic interventions to improve health outcomes in heart transplant patients. Specific clinical focus areas include immune tolerance, chronic rejection, infection prevention, prevention of malignancy, coronary allograft vasculopathy, predictive biomarkers, and the incorporation of artificial intelligence or other technologies.
Award structure and compliance
Review the likely award, project window, cost rules, and pre-application conditions that shape a viable proposal.
Who Can Apply
Applicants must hold an MD, PhD, DO, DVM, DDS, DNP, or equivalent post-baccalaureate doctoral degree and be employed at a qualified U.S.-based non-profit institution. Applicants must be active Professional Members of the American Heart Association at the time of proposal submission, self-register as peer reviewers, and maintain an eligible U.S. citizenship or visa status (U.S. citizen, permanent resident, pending permanent resident, H1-B Visa, O-1 Visa, TN Visa, or DACA). Trainees and fellows are not eligible.
Open to applicants from
Not specified
Education levels
Phd, Professional
Not sure you qualify? MorrowGuide checks each rule against your profile and shows what is still unknown.
Key Dates
Applications Open
Application Deadline
What’s included
The grant provides funding of $100,000 over a 12-month period. This funding can be used for salary and fringe benefits for principal and collaborating investigators, salaries for technical personnel, and project-related expenses such as supplies, equipment, computers/electronics, travel (including international travel), volunteer subject costs, data management, and publication costs, including up to 10% in institutional indirect costs.
Award amount
$100,000
Application requirements
Applicants must submit their proposals electronically via ProposalCentral by Tuesday, December 15, 2026, at 3 p.m. Central Time. All applicants must be Professional Members of the American Heart Association at submission and self-register as peer reviewers on ProposalCentral. Submissions require the signature of an authorized institutional representative. Evaluation involves a distributed peer review process where applicants review assigned proposals.
Proposed Research Plan (5 pages)
Statement of Qualifications of the PI and study team (1 page)
Target Agencies and Funders for the Final Proposal Submission (1 page)
Applicant Biosketch
Research Project Environment Form (DOCX) (2 pages)
Budget Justification Form (DOCX ) (2 pages)
Literature Cited (4 pages)
Vertebrate Animal Subjects (if applicable, no page limit)
Collaborating Investigator's Biosketch
Collaborating Investigator's Letter (2 pages)
Consultant's Letter (2 pages)